EUVIMEDEUVIMED entdecken
Mixed-Methods-StudieOpen Access · CC BY 4.0

Extended difficulties following the use of psychedelic drugs: A mixed methods study

Jules Evans, Oliver C Robinson iD, Eirini Ketzitzidou Argyri iD, Shayam Suseelan, Ashleigh Murphy-Beiner, Rosalind McAlpine, David Luke iD, Katrina Michelle, Ed Prideaux

PLOS ONE · 24.10.2023 · 18 (10) · e0293349

DOI: 10.1371/journal.pone.0293349 ↗

Kurz gefasst

Mixed-Methods-Studie in der Zeitschrift PLOS ONE, online erschienen am 24.10.2023. Verfasst von Jules Evans und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for the History of Emotions, Queen Mary University, London, United Kingdom. Hauptthemen laut MEDLINE: Hallucinogens. Die Arbeit wurde bisher 185-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Emergence Benefactors.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long-term adverse experiences following psychedelic use can persist for weeks, months, or even years, and are relatively unexplored in psychedelic research. Our convergent mixed-method study gained quantitative and qualitative data from 608 participants who reported extended difficulties following psychedelic experiences. Data was gathered on the context of use, the nature and duration of the challenges they experienced (including a written description of these), plus a range of possible risk factors and perceived causes. The most common forms of extended difficulty were feelings of anxiety and fear, existential struggle, social disconnection, depersonalization and derealization. For approximately one-third of the participants, problems persisted for over a year, and for a sixth, they endured for more than three years. It was found that a shorter duration of difficulties was predicted by knowledge of dose, drug type and lower levels of difficulty reported during the psychoactive experience, while a narrower range of difficulties was predicted by taking the drug in a guided setting. Implications for psychedelic harm reduction are discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HallucinogensHumansEmotionsAnxietyFearAnxiety Disorders

Substanzen

Hallucinogens

Autor:innen und Institutionen

  • Centre for the History of Emotions, Queen Mary University, London, United Kingdom.
  • School of Human Sciences, University of Greenwich, London, United Kingdom.
  • Psychology Department, University of Exeter, Exeter, United Kingdom.
  • Department of Psychology, Royal Holloway, London, United Kingdom.
  • Division of Psychology & Language Sciences, University of College London, London, United Kingdom.
  • Department of Applied Psychology, New York University, New York, New York, United States of America.

ORCID-Profile: Oliver C Robinson, Eirini Ketzitzidou Argyri, David Luke

Förderung

  • Emergence Benefactors

Zitieren

APA

Evans, J., Robinson, O. C., Argyri, E. K., Suseelan, S., Murphy-Beiner, A., McAlpine, R., Luke, D., Michelle, K., & Prideaux, E. (2023). Extended difficulties following the use of psychedelic drugs: A mixed methods study. PLOS ONE, 18(10), e0293349. https://doi.org/10.1371/journal.pone.0293349

Vancouver

Evans J, Robinson OC, Argyri EK, Suseelan S, Murphy-Beiner A, McAlpine R, et al. Extended difficulties following the use of psychedelic drugs: A mixed methods study. PLOS ONE. 2023;18(10):e0293349. doi:10.1371/journal.pone.0293349

BibTeX
@article{Evans2023,
  author = {Evans, Jules and Robinson, Oliver C and Argyri, Eirini Ketzitzidou and Suseelan, Shayam and Murphy-Beiner, Ashleigh and McAlpine, Rosalind and Luke, David and Michelle, Katrina and Prideaux, Ed},
  title = {Extended difficulties following the use of psychedelic drugs: A mixed methods study},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {10},
  pages = {e0293349},
  doi = {10.1371/journal.pone.0293349}
}
Kostenlos starten →